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Abstract
Rationale:Complement deficiency are known to be predisposed to disseminated gonococcal infection (DGI). We herein present a
case of DGI involving a Japanese man who latently had a complement 7 deficiency with compound heterozygous variants.
Patientconcerns:A previously healthy 51-year-old Japanese man complained of sudden-onset high fever. Physical examination
revealed various skin lesions including red papules on his trunk and extremities, an impetigo-like pustule on left forearm, and tendinitis
of his right forefinger.
Diagnosis:Blood culture testing detected gram-negative cocci, which was confirmed to beNeisseria gonorrhoeae based onmass
spectrometry and a pathogen-specific PCR test.
Interventions: Screening tests for underlying immunocompromised factors uncovered that complement activities (CH50) was
undetectable. With a suspicion of a congenital complement deficiency, genetic analysis revealed rare single nucleotide variants in
complement 7 (C7), including c.281-1G>T and a novel variant c.1454C>T (p.A485V). CH50 was normally recovered by adding
purified human C7 to the patient’s serum, supporting that the patient has C7 deficiency with compound heterozygous variants.
Outcomes: Under a diagnosis of DGI, the patient underwent an antibiotic treatment with cefotaxime for a week and was
discharged without any sequela.
Lessons: DGI is a rare sexually-transmitted infection that potentially induces systemic complications. Complement immunity
usually defeats N. gonorrhoeae and prevents the organism from causing DGI. This case highlighted the importance of suspecting a
complement deficiency when a person develops DGI.
Abbreviations: CH50 = complement activity, DGI = disseminated gonococcal infection.
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Neisseria gonorrhoeae infection is a very common sexually-
transmitted disease with about 78 million cases per year
worldwide,[1] which usually causes localized genital infections
in young adult populations. Infrequently (only about 0.5%–3%
of the primary sexual mucosal infection),[2] the pathogen invades
into blood through the mucous membranes of the urethra, cervix,
rectum, oropharynx, or conjunctivae,[3] causing disseminated
gonococcal infection (DGI). Patients with DGI manifest a wide
variety of complications, such as tenosynovitis, dermatitis, and
polyarthralgia, and even fatal infections including endocarditis,
meningitis, and osteomyelitis.[4] Recently, multidrug-resistant N.
gonorrhoeae has globally emerged and the pathogen poses an
emerging threat to the public health.[5,6]
Complement plays an essential portion of the innate immune
system by purging bacteria from human body via pore-
forming complexes.[7] To date, an association of DGI and the
complement deficiency (C1r,[8] C2,[9] C5,[10] C6, C7,[11,12] and
C8[12–14]) has been reported, and we should note that patients
with a complement deficiency possibly undergo refractory
neisserial bacteremia.[12] Even hypocomplementemia can under-
mine the prevention of gonococcal dissemination.[8,15,16] As far
as we concern, the literature has rarely described such a case in
Japanese population. Herein, we describe a case of DGI that
involved a Japanese man with complement 7 deficiency, which
was confirmed by genome analysis and complement addition test.
2. Case presentation
A 51-year-old man who experienced an acute-onset high fever
presented to us. His past medical history included spontaneous
pneumothorax, tonsillectomy, and Wolff–Parkinson–White syn-
drome. At the presentation, there was no respiratory, gastrointes-
tinal, or urinary symptoms. He denied any previous history of
repeated or refractory infectious episodes. His vital signs were as
follows: body temperature, 38.8oC; blood pressure, 115/56mm
Hg; heart rate, 110beats perminute, sinus, and oxygen saturation,
99% on room air. Physical examination revealed red papules on
his trunk and extremities (Fig. 1A, B). A pustular lesion on right
forearm showed an impetigo-like appearance (Fig. 1C), and the
patient complained tendinitis at proximal interphalangeal joint of
his right forefinger (Fig. 1D). Laboratory tests showed elevationsof
peripheralwhiteblood cells (17,300/mL), serumC-reactive protein
Figure 1. Skin manifestations of disseminated gonococcal infection. There were red papules on his trunk and extremities (A and B), an impetigo-like pustular lesion
on left forearm (C), and tendinitis at proximal interphalangeal joint of right forefinger (D).
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(6.56mg/dL), and procalcitonin (2.38ng/mL); otherwise, there
was no particular findings including urinalysis. Screening tests for
sexually-transmitted infections suchas syphilis, hepatitis B/Cvirus,
and human immunodeficiency virus were all negative. Under a
tentative diagnosis of a systemic febrile disease, and submitted
blood culture samples (BD BACTEC FX blood culture system;
Becton Dickinson, Sparks, MD). The patient was prescribed oral
levofloxacin and returned home. Next day, gram-negative cocci
was detected in the 2 sets of aerobic blood cultures, and the patient
was hospitalized with suspicion of a systemic neisserial infection.
The pathogen could not be identified by matrix-assisted laser
desorption/ionization-time of flight mass spectrometry (MALDI
Biotyper; Bruker Daltonics, Bremen, Germany) directly using
positive blood culture bottles. We subcultured the organism on
5% sheep blood (Becton Dickinson) and modified Thayer–
Martin agar (Becton Dickinson). We then identified the pathogen
as N. gonorrhoeae by means of colony-direct MALDI-TOF MS
with a high score value of 2.405. A biochemical assay also
confirmed it to beN. gonorrhoeaewith an accuracy of>99% (ID
test HN-20 rapid; Nissui, Tokyo, Japan). Further, we finally
corroborated the organism to be N. gonorrhoeae via a specific
PCR testing targeting the piv gene. The organism was not
identified from intranasal, throat, and urine samples. On the basis
of disk diffusion method, the organism was susceptible to
cefotaxime and azithromycin, while resistant to ciprofloxacin
and tetracycline.
After admission, we initiated cefotaxime (6g per day). Fever as
well as the various dermatologic manifestations subsided
promptly, and the patient was discharged after 7 days of
intravenous treatment. Later, detailed history taking revealed
several episodes of sexual intercourse with commercial sex
workers. The last sexual contact was 2 months before, and the
patient denied any symptoms suggesting urethritis.
3. Investigations for complement deficiency
We suspected a presence of any underlying conditions, especially
humoral-immune deficiency, for developing DGI in this patient.
As a result of investigation, we found that C3 (120mg/dL;
reference range, 86–160mg/dL) and C4 (33mg/dL; reference
range, 17–45mg/dL) were within normal ranges, while comple-
ment activity (CH50) was undetectable. Considering a congenital
complement deficiency, we submitted his blood sample to the
Japanese Association for Complement Research with a consent
from the patient. Whole exome analysis of 115 complement
associated genes using MiSeq (Illumina, San Diego, California)
found rare (allele frequency<0.005) heterozygous genetic variants
in complement C7; c.281-1G>T at 3’ splice site of intron 4 and
c.1454C>T (p.A485V) in exon 11. We confirmed that those
variants are located on different chromosomes by sequencing
amplified fragments from exon 5 to 7 including c.281-1G>T and
fragments from exon 7 to 11 including c.1454C>T. CH50 of the
patient’s serum was recovered to normal range (49.0CH50/mL)
with a supplement of purified human C7 protein (50mg/mL) in
vitro, supporting that thepatient hasC7deficiencywith compound
heterozygous variants.
4. Discussion
We presented a rare case of DGI that involved a patient with a
complement 7 deficiency. Although similar cases have been
reported worldwide,[8–14] this may be the first such documented
report in Japan accompanying a detailed genetic background.We
could suspect the possibility of complement deficiency with the
result of undetectable CH50 activity, despite normal activities of
C3 and C4 components. The patient denied any previous history
of repeated or refractory infections, possibly suggesting an
immunocompromised condition. Thus, even the patient himself
had never suspected the complement deficiency as his underlying
disease until at his age.
A MEDLINE research uncovered that there have been 13 DGI
cases in the literature in Japan[16–18]; however, an investigation
for complement deficiency was not done in any of the cases.
Homozygous but not heterozygous mutation c.281-1G>T has
been previously reported to cause C7 deficiency.[19] The alanine-
485 is well preserved in vertebrate animals, suggesting that the
novel variant c.1454C>T (p.A485V) is contributing to C7
deficiency in a compound-heterozygous manner in our case.
CH50 recovery by adding purified C7 to the patient’s serum
supports this hypothesis.
Causal relationship between the C7 deficiency and develop-
ment of DGI is yet to be elucidated in the literature. Terminal
complement components, including C7, have been corroborated
to be essential elements for preventing a development of invasive
neisserial infections.[20] Its complete deficiencies predispose
patients to a great risk of recurrent neisserial infection, and in
fact, patients with homozygous C7 deficiency are reported to be
vulnerable to the severe disease during childhood and adoles-
cence.[21,22] Previously, it was estimated that individuals with C7
or C9 deficiency may develop invasive meningococcal disease at
10,000- or 1400-fold greater risk compared to those without the
complement deficiency.[23] Pathophysiologically, patients with
compound-heterozygous terminal complement deficiency, like
our patient, show undetectable CH50 activity as patients with
homozygous deficiency does.[23] Indeed, a molecular-based study
described that 4 patients with C7 deficiency with compound
heterozygous variants had undetectable CH50 activities, and had
past histories of meningococcal systemic infections.[24] Thus, we
speculate that C7 deficiency with compound heterozygous
variants would be a predisposing factor for DGI, as a
consequence of zero-level CH50 activity. One previous review
referred that lowered levels of terminal complement, which
occurs as a result of heterozygous deficiency, can function to
prevent the neisserial infection.[21] In fact, among 13 young
Japanese patients (19–42 years-old) with C5–8 deficiencies, 12
had no past medical history suggesting repeated infections.[25]
The terminal complement deficiencies are rare but should not
be overlooked. According to a population-based screening test
using blood donor samples collected at Osaka (Japan), the
incidence of C9 deficiency was about 0.095%, accounting for
most common complement deficiency in Japan.[26] C7 deficiency
is known to be the secondmost common type among complement
deficiencies (0.0041%).[25]
DGI potentially yields various dermatologic presentations,
such as hemorrhagic pustules, petechiae, and purpuric lesions.[27]
Our patient also manifested a variety of skin findings, including
red papule, impetigo-like pustule, and tendinitis. In addition to a
rarity of the disease, this diversity in presentation make it difficult
to diagnose or suspect clinically. Physicians should remind of
DGI in cases sexually active persons manifested pyrexia with
various cutaneous findings.
A plausible reason for the prolonged latent period (2months)
between the last sexual contact and the onset of DGI was
uncertain in this case. Though infrequent when compared to
women, asymptomatic gonococcal infections are possible
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amongst men; latency periods of asymptomatic gonococcal
infections could range from 3 to 154days in men.[28] Thus, we
speculate that the pathogen could hide out somewhere in his body
such as urethra and pharynx for that long term. Or, just simply,
the patient might have withheld the truth about his real sexual
contact history.
In conclusion, we reported a rare case of DGI in a Japanese
man. Molecular exploration uncovered the patient to have C7
deficiency with compound heterozygous variants as an underly-
ing disease. We should be aware that terminal complement
deficiency, involving approximately 1 in 1000 Japanese people,
potentially exposes a greater risk of severe neisserial infections.
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